Skip to content

Clinical trials

Phase 3 Respiratory Tract Diseases trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Diseases Phase: Phase 3 Country / region: China Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20111
20172
20193
20222
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting2
Active, not recruiting1
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
United Therapeutics2
AstraZeneca1
Bellus Health Inc. - a GSK company1
Chinese Society of Lung Cancer1
Eli Lilly and Company1
GlaxoSmithKline1
Jiangsu HengRui Medicine Co., Ltd.1
Pfizer1
Shanghai Zhongshan Hospital1
Zambon SpA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Tract Diseases11
Lung Diseases6
Lung Neoplasms3
Thoracic Neoplasms3
Bronchial Neoplasms2
Carcinoma, Bronchogenic2
Carcinoma, Non-Small-Cell Lung2
Cardiovascular Diseases2
Connective Tissue Diseases2
Cough2

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.